SAN FRANCISCO (MarketWatch) — GameStop Corp. shares jumped in the extended session after the video-game retailer said holiday demand for games was strong and that it expects the trend to continue in the first quarter.
GameStop /zigman2/quotes/203755179/composite GME -6.24% shares surged 7.7% to $35.30 on moderate volume. The company said it expects a narrower decline in same-store sales than it had previously forecast.
CSX Corp. /zigman2/quotes/208536759/composite CSX +0.46% shares rose 1% to $33.87 on moderate volume after the railroad operator reported fourth-quarter results in-line with what analysts expected and forecast double-digit earnings-per-share growth in 2015.
Linear Technology Corp. shares rose 3.9% to $46.93 on moderate volume after the electronics component maker reported quarterly earnings of 51 cents a share on revenue of $352.6 million. Analysts had forecast 49 cents a share on revenue of $354.5 million. The company also hiked its quarterly dividend 10% to 30 cents a share.
Shares of Progress Software Corp. /zigman2/quotes/205828109/composite PRGS +1.11% shares dropped 10% to $23.75 on moderate volume after the company said it expects adjusted fiscal first-quarter earnings of 22 cents to 24 cents a share on revenue of $93 million and $96 million. Analysts surveyed by FactSet estimate 31 cents a share on revenue of $81 million.
Tesla Motors Inc. /zigman2/quotes/203558040/composite TSLA +3.62% shares fell 7.1% to $189.73 on moderate volume following a report that sales of electric cars in China declined significantly in the last quarter.
Shares of Ziopharm Oncology Inc. and Intrexon Corp. rallied after the partner biotechs announced an exclusive licensing agreement with the University of Texas MD Anderson Cancer Center for the use of next-generation cancer therapies. Ziopharm shares /zigman2/quotes/200291745/composite ZIOP -3.58% jumped 25% to $7.19 on heavy volume, while Intrexon shares rose 6% to $30.10.
Caesars Entertainment Corp.’s /zigman2/quotes/207192848/composite CZR +0.18% largest unit plans to file a voluntary Chapter 11 bankruptcy petition in the next few days, The Wall Street Journal reported late Tuesday.
These were the stocks making notable moves in Tuesday’s regular session.
Apple Inc. /zigman2/quotes/202934861/composite AAPL -0.10% was upgraded to outperform from neutral and given a price target of $130 by Credit Suisse analysts, who cited strong iPhone sales and expectations the tech giant will return more cash to shareholders.
Celgene Corp. on Monday said its 2014 sales are likely to rise by double digits but warned that volatile foreign-currency rates will impact sales of its blood cancer drug Revlimid in 2015.
Analysts at Stifel Nicolaus raised the target price on Monster Beverage Corp.’s /zigman2/quotes/205899417/composite MNST +1.47% stock to $130 from $115, citing the company’s deal with Coca-Cola Co. /zigman2/quotes/209159848/composite KO -0.87% and more equity dilution.
Aetna Inc. said it expects 2014 earnings per share at the high end of its forecast range of $6.60 to $6.70, and said medical memberships will exceed projections.